AVXL:NASDAQ
Anavex Life Sciences Corp
$2.66
arrow_downward
-3.27%(-0.090) 1D
$2.70
arrow_upward
+1.50% (+0.040)todayPre-market
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVXL...
Open
$2.71
High
$2.74
Low
$2.62
Mkt. cap
246.57M
Avg. vol.
865.28K
Volume
4.66K
52-wk high
$10.38
52-wk low
$2.26
EPS
-$0.15
Beta
1.14
Shares outstanding
92.70M
No. of employees
34
Open
$2.71
High
$2.74
Low
$2.62
Mkt. cap
246.57M
Avg. vol.
865.28K
Volume
4.66K
52-wk high
$10.38
52-wk low
$2.26
EPS
-$0.15
Beta
1.14
Shares outstanding
92.70M
No. of employees
34
News stories
From web sources and news partners
TipRanks
·
1 day ago
Anavex Advances Rett Syndrome Phase 3 Trial Plans
Stock Titan
·
1 day ago
Activist PVG targets Anavex (NASDAQ: AVXL) board, urging investors to back its slate in 2026
TradingView
·
1 day ago
AVXL: Refocused on three core indications, regained compliance, and committed to transparency
Anavex Life Sciences
·
1 day ago
Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteanavex.com